Stay updated on Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-05T21:05:33.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    16 days ago
    No Change Detected
  5. Check
    23 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added and the government funding status notice, along with the Revision: v3.4.1 label, was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:50:07.000Z thumbnail image
  6. Check
    30 days ago
    Change Detected
    Summary
    A government funding/status notice was added and the page template updated to Revision: v3.4.1, replacing the previous v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T00:39:33.000Z thumbnail image
  7. Check
    37 days ago
    Change Detected
    Summary
    Footer and help-section updates were made, including glossary display and IPD-related links. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    55%
    Check dated 2026-01-28T00:24:14.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    A new Locations section is added, listing Osaka and additional prefectures (Aichi-ken, Hokkaido, Kumamoto, Shizuoka, Tokyo) and the page revision updated to v3.3.3. The HHS Vulnerability Disclosure link and prior location entries (Aichi-ken Locations, Hokkaido Locations, Kumamoto Locations, Shizuoka Locations, Tokyo Locations) were removed.
    Difference
    0.6%
    Check dated 2025-12-23T08:10:52.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.1 to v3.3.2 on the Study Details page. No study data, eligibility criteria, outcomes, or locations appear to be affected.
    Difference
    0.1%
    Check dated 2025-12-01T16:48:20.000Z thumbnail image

Stay in the know with updates to Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page.